CureVac
Maarten Van den Boer has a diverse work experience in the medical field. Maarten is currently serving as the Medical Director Infectious Diseases at CureVac since September 2022. Prior to that, they worked as the Medical Director at ExeVir from January 2022 to July 2022. From October 2020 to January 2022, they were the Clinical Research and Development Lead at GSK Vaccines. Before that, they held various roles at Janssen Inc., including Director-Exploratory Patient Study Clinical Leader from June 2017 to October 2019, and Associate Director-Research Physician from May 2013 to May 2017. Maarten'searly work experience includes training in internal medicine at UZA from 2007 to November 2012, and training at a medical group in the region of Noord-Brabant from 2005 to 2007.
Maarten Van den Boer earned a Master's degree from the University of Antwerp in Algemene geneeskunde in 2005. Maarten then obtained another Master's degree from the same university in an unspecified field of study in 2012.
This person is not in any offices
CureVac
8 followers
CureVac is a global biopharmaceutical company in the field of messenger RNA (mRNA) technology, with more than 20 years of expertise in developing and optimizing the versatile biological molecule for medical purposes. The principle of CureVac’s proprietary technology is the use of non-chemically modified mRNA as a data carrier to instruct the human body to produce its own proteins capable of fighting a broad range of diseases.